PCOS Renamed PMOS to Better Reflect Broader Health Impacts

A century-old medical condition, previously known as Polycystic Ovary Syndrome (PCOS), has been officially renamed "Poliendokrini Metabolički Ovarijalni Sindrom" (PMOS). The change, detailed in a recent "Lancet" publication, stems from over a decade of advocacy by researchers and patients.

“

It actually weren't true cysts at all.

When first identified by surgeons a hundred years ago, the condition was characterized by what appeared to be small sacs on the ovaries, coupled with high male hormone levels and infertility. Doctors named it PCOS, believing the "cysts" were the primary issue. However, extensive research over the past century revealed that these were not true cysts but rather halted egg development, a symptom of a wider endocrine disorder impacting metabolism, cardiovascular health, and skin. Studies show individuals with PCOS have a significantly higher risk of Type 2 diabetes and heart disease.

“

There is no other condition that I treat where almost every single person who walks into my office ends up crying because someone listened to them. I have boxes of tissues.

Dr. Helena Tid, an endocrinologist and professor of women's health at Monash University, explains that the "cysts" were actually immature egg follicles. The new name, PMOS, aims to accurately represent the condition as a systemic endocrine and metabolic issue. Advocates, including Rachel Morman, president of the PCOS charity "Verity UK," believe the rebranding will unlock more research funding and enhance understanding among both medical professionals and patients. Morman notes that many women with PCOS still believe they have ovarian cysts, and some healthcare providers share this misconception, leading to difficulties in receiving appropriate care and validation.

“

There was still a very, very large number of women with this condition who believed they had ovarian cysts, and, worryingly, a huge number of specialists who also believed that.